BACKGROUND: Laparoscopic greater curvature plication (LGCP) is an innovative restrictive technique designed to reduce gastric volume by plication at the region of greater curvature. The long-term efficacy, safety, and the metabolic effects of this procedure are the subject of this study. METHODS: One hundred twenty-seven patients were enrolled; 84 underwent laparoscopic sleeve gastrectomy (LSG) and 43, LGCP. LSG and LGCP were then compared during long-term follow-ups in terms of glycemic control, hormone and lipid secretion, and changes in body composition. Measured parameters included serum glucose, triglycerides, high- and low-density lipoprotein cholesterol, testosterone, estradiol, leptin, adiponectin, ghrelin, fatmass, and lean body mass. RESULTS: Significant weight-loss and a reduced body composition resulted from either procedure vs. baseline (i.e., pre-surgery), with levels of fasting glucose and glycated hemoglobin also showing statistically significant reductions (at 3 and 18 months for either surgery). Intergroup comparisons for glycemic parameters yielded no statistically significant differences. However, a dramatic reduction in ghrelin was detected following LSG, falling from pre-surgery levels of 140.7 to 69.6 ng/L by 6 months (P < 0.001). Subsequently, ghrelin levels increased, reaching 107.8 ng/L by month 12. Conversely, after LGCP, a statistically significant increase in ghrelin was seen, rising from 130.0 ng/L before surgery to 169.0 ng/L by month 12, followed by a slow decline. CONCLUSIONS: Good metabolic outcomes were obtained following LGCP, which might be mediated via altered glucose metabolism and GI hormones. Nevertheless, this method is less effective than LSG, possibly due to its preservation of the entire stomach, including secretory regions.

Department of Epidemiology and Public Health Faculty of Medicine University of Ostrava Syllabova 19 703 00 Ostrava Czech Republic

Department of Physiology and Pathophysiology Faculty of Medicine University of Ostrava Syllabova 19 703 00 Ostrava Czech Republic

Department of Surgical Studies Faculty of Medicine University of Ostrava Syllabova 19 703 00 Ostrava Czech Republic

Institute of Laboratory Diagnostics University Hospital Ostrava 17 listopadu 1970 5 Ostrava Czech Republic

Zobrazit více v PubMed

Int J Surg. 2015 Nov;23(Pt A):101-7 PubMed

Cir Esp. 2010 Aug;88(2):103-9 PubMed

J Clin Endocrinol Metab. 2004 Jun;89(6):2659-64 PubMed

Surg Endosc. 2011 Aug;25(8):2498-504 PubMed

Asian J Surg. 2016 Jan;39(1):21-8 PubMed

Cir Esp. 2011 Jun-Jul;89(6):356-61 PubMed

Obes Surg. 2014 Jan;24(1):85-94 PubMed

Wideochir Inne Tech Maloinwazyjne. 2014 Dec;9(4):554-61 PubMed

Trends Endocrinol Metab. 2016 Jan;27(1):54-63 PubMed

J Obes. 2011;2011:350523 PubMed

J Laparoendosc Adv Surg Tech A. 2007 Dec;17(6):793-8 PubMed

J Clin Endocrinol Metab. 2001 Oct;86(10):4753-8 PubMed

Obes Surg. 2010 Aug;20(8):1171-7 PubMed

Surg Obes Relat Dis. 2013 Jan-Feb;9(1):21-5 PubMed

Ann Surg. 2010 Aug;252(2):319-24 PubMed

Obes Surg. 2006 Apr;16(4):469-77 PubMed

Obes Surg. 2013 Jul;23(7):939-46 PubMed

Am Heart J. 2005 Jan;149(1):33-45 PubMed

Obes Surg. 2005 Aug;15(7):1024-9 PubMed

Nutr Res. 2010 Mar;30(3):163-70 PubMed

J Surg Res. 2016 May 15;202(2):449-54 PubMed

Obes Surg. 2016 Jun;26(6):1167-72 PubMed

Am J Surg. 2015 Feb;209(2):230-4 PubMed

JAMA. 2004 Oct 13;292(14):1724-37 PubMed

J Clin Anesth. 2016 Nov;34:85-90 PubMed

Obes Surg. 2012 Aug;22(8):1298-307 PubMed

Obes Surg. 2011 Mar;21(3):305-9 PubMed

N Engl J Med. 2011 Oct 27;365(17):1597-604 PubMed

Semin Pediatr Surg. 2014 Feb;23(1):24-30 PubMed

Clin Endocrinol (Oxf). 2002 Feb;56(2):203-6 PubMed

Int J Surg. 2016 Apr;28:131-5 PubMed

Obes Surg. 2011 Nov;21(11):1657-63 PubMed

Obes Surg. 2014 May;24(5):718-26 PubMed

Obes Surg. 2017 Jan;27(1):38-43 PubMed

J Visc Surg. 2012 Oct;149(5):e350-5 PubMed

Obes Surg. 2012 May;22(5):740-8 PubMed

Prevention of sarcopenia in patients with obesity after bariatric and metabolic surgery: The effect of programmed training on the muscle tissue and anthropometric functions - A randomized controlled trial (SarxOb study protocol)

The risk of sarcopenia 24 months after bariatric surgery - assessment by dual energy X-ray absorptiometry (DEXA): a prospective study

Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP

Zobrazit více v PubMed

ClinicalTrials.gov
NCT02893891